Clinical Trial Update: Evaluation of Quality of Care - Risk Assessment Management Programme, HA

View source ↗

Summary

Completed evaluation of a quality-of-care risk assessment management programme for diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: The University of Hong Kong | Conditions: Diabetes Mellitus | Status: COMPLETED